Stay updated on Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Sign up to get notified when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.

Latest updates to the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a version upgrade.SummaryDifference0.0%

- Check43 days agoChange Detected- Revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check72 days agoChange DetectedMinor platform update: Revision: v3.4.2 added and Revision: v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check79 days agoChange DetectedMinor site revision updating from v3.4.0 to v3.4.1 with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check86 days agoChange DetectedThe update adds a glossary toggle and updates UI/metadata labels, including capitalization changes for QC criteria text and the No FEAR Act Data label, and upgrades the revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.